JAZZ PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.72 BRL | -0.56% |
|
-.--% | -10.95% |
Business Summary
Number of employees: 2,800
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 3,659 | 100.0 % | 3,834 | 100.0 % | +4.78% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
91.0
%
| 3,370 | 92.1 % | 3,490 | 91.0 % | +3.55% |
Europe
7.0
%
| 240 | 6.5 % | 269 | 7.0 % | +12.35% |
All Other
2.0
%
| 49 | 1.3 % | 75 | 2.0 % | +51.92% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/01 |
Renée Galá
PSD | President | 52 | 16/20/16 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29/19/29 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/12/18 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01/18/01 |
Neena Patil
LAW | General Counsel | 49 | 01/19/01 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/01 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13/13/13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01/09/01 |
Peter Gray
BRD | Director/Board Member | 69 | 08/13/08 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01/04/01 |
Rick Winningham
BRD | Director/Board Member | 64 | 01/10/01 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/12/18 |
Heather McSharry
BRD | Director/Board Member | 62 | 02/13/02 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27/12/27 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14/19/14 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 63,039,618 | 61,286,901 ( 97.22 %) | 0 | 97.22 % |
Company contact information
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.com
Group companies
| Name | Category and Sector |
|---|---|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Holdings Ltd.
 Jazz Financing Holdings Ltd. MiscellaneousMiscellaneous Part of Jazz Pharmaceuticals Plc, Jazz Financing Holdings Ltd. is an investment holding Irish company. The company is located in Ireland. |
Miscellaneous
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Ltd.
 Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Lux SARL
 Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Sector
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
106.3
USD
Average target price
180.3
USD
Spread / Average Target
+69.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +45.82% | 754B | |
| +40.95% | 630B | |
| -6.16% | 352B | |
| +19.86% | 331B | |
| +9.32% | 298B | |
| +18.45% | 250B | |
| +11.88% | 217B | |
| -0.78% | 216B | |
| +5.90% | 164B |
- Stock Market
- Equities
- JAZZ Stock
- J2AZ34 Stock
- Company Jazz Pharmaceuticals plc
